SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fridén Markus)
 

Search: WFRF:(Fridén Markus) > Revealing the Regio...

Revealing the Regional Localization and Differential Lung Retention of Inhaled Compounds by Mass Spectrometry Imaging

Hamm, Gregory R. (author)
AstraZeneca, BioPharmaceut R&D, Pathol Sci, Clin Pharmacol & Safety Sci, Cambridge CB4 0WG, England
Bäckström, Erica (author)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp Inflammat & Autoimmune, Gothenburg, Sweden
Brülls, Mikael (author)
AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Prod Dev, Gothenburg, Sweden
show more...
Nilsson, Anna (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab
Strittmatter, Nicole (author)
AstraZeneca, BioPharmaceut R&D, Pathol Sci, Clin Pharmacol & Safety Sci, Cambridge CB4 0WG, England
Andrén, Per E. (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab
Grime, Ken (author)
AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp Inflammat & Autoimmune, Gothenburg, Sweden
Fridén, Markus (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,AstraZeneca, BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev,Resp Inflammat & Autoimmune, Gothenburg, Sweden
Goodwin, Richard J. A. (author)
AstraZeneca, BioPharmaceut R&D, Pathol Sci, Clin Pharmacol & Safety Sci, Cambridge CB4 0WG, England
show less...
 (creator_code:org_t)
Mary Ann Liebert Inc, 2020
2020
English.
In: Journal of Aerosol Medicine. - : Mary Ann Liebert Inc. - 1941-2711 .- 1941-2703. ; 33:1, s. 43-53
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: For the treatment of respiratory disease, inhaled drug delivery aims to provide direct access to pharmacological target sites while minimizing systemic exposure. Despite this long-held tenet of inhaled therapeutic advantage, there are limited data of regional drug localization in the lungs after inhalation. The aim of this study was to investigate the distribution and retention of different chemotypes typifying available inhaled drugs [slowly dissolving neutral fluticasone propionate (FP) and soluble bases salmeterol and salbutamol] using mass spectrometry imaging (MSI).Methods: Salmeterol, salbutamol, and FP were simultaneously delivered by inhaled nebulization to rats. In the same animals, salmeterol-d(3), salbutamol-d(3), and FP-d(3) were delivered by intravenous (IV) injection. Samples of lung tissue were obtained at 2- and 30-minute postdosing, and high-resolution MSI was used to study drug distribution and retention.Results: IV delivery resulted in homogeneous lung distribution for all molecules. In comparison, while inhalation also gave rise to drug presence in the entire lung, there were regional chemotype-dependent areas of higher abundance. At the 30-minute time point, inhaled salmeterol and salbutamol were preferentially retained in bronchiolar tissue, whereas FP was retained in all regions of the lungs.Conclusion: This study clearly demonstrates that inhaled small molecule chemotypes are differentially distributed in lung tissue after inhalation, and that high-resolution MSI can be applied to study these retention patterns.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Keyword

lung retention
mass spectrometry imaging
pharmacokinetics
pulmonary distribution

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view